PureCycle Technologies Inc Ordinary Shares (PCT)

Industry Pollution & Treatment Controls


This stock can be held in an Investment ISA and an Investment Account
Sell

$8.66

Buy

$9.05

arrow-down$-0.66 (-6.99%)

Prices updated at 13 Dec 2025, 00:20 EST
| Prices minimum 15 mins delay
|
Prices in USD

Sector
Industrials
Industry
Pollution & Treatment Controls
Chairman
Mr. Daniel M. Coombs
CEO
Mr. Dustin Olson
Most recent earnings
31 Dec 2024
Fiscal year end
31 Dec 2024
Employees
157
Head office
20 North Orange Avenue
Orlando
United States
32801
mobile
+1 877 648-3565
letter
-

Key personnel

Salary
Mr. Daniel Gibson
Director
-
Dr. Siri Jirapongphan
Independent Director
-
Mr. Steven F. Bouck
Independent Director
0.11m
Mr. Jaime Vasquez
Chief Financial Officer
0.43m
Mr. Brad S. Kalter
Chief Compliance Officer, General Counsel and Corporate Secretary
0.42m
Mr. Daniel M. Coombs
Non-Executive Chairman of the Board
0.08m
Mr. Fernando Musa
Independent Director
0.10m
Mr. Dustin Olson
Director and Chief Executive Officer
0.77m
Ms. Tanya Burnell
Independent Director
0.12m
Mr. Jeffrey Fieler
Independent Director
-
Mr. Allen W. Jacoby
Lead Independent Director
0.12m
Mr. Gregory Barta
Corporate Controller and Chief Accounting Officer
-

Top 5 shareholders

No. of shares
Sylebra Capital LLC34,077,574
Vanguard Group Inc15,387,891
Longview Management Group LLC9,716,394
BlackRock Inc9,612,609
Vanguard Investments Australia Ltd5,174,298

Director dealings

Action
04 Dec 2024-
04 Nov 2024-
04 Oct 2024-
23 Sep 2024-
04 Sep 2024-
13 Aug 2024-
05 Aug 2024-
04 Aug 2024-
08 Jul 2024-
08 Jul 2024-
04 Jul 2024-
04 Jun 2024-
20 May 2024-
14 May 2024-
08 May 2024-
08 May 2024-
08 May 2024-
08 May 2024-
08 May 2024-
08 May 2024-
Please note that past performance is not a reliable indicator of future returns.


Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.